Newsroom
Newsroom
Industry News
Our co-founder and CEO, Christina Smolke, was named to Forbes’ list of top ten women founders taking the synthetic biology world by storm. From her...
Blog Posts
We’ve recently welcomed Jesse Ahrendt, our new Senior Vice President of Quality Assurance and Regulatory Affairs, who will lead our quality and regulatory efforts. He...
Blog Posts
At Antheia, we spend a lot of time talking about synthetic biology due to the nature of our work engineering yeast to produce active pharmaceutical...
Blog Posts
This year has been ripe with growth, major achievements, and opportunities to showcase who and what make Antheia the visionary business it is. Nearly eight...
Industry News
Drug Discovery and Development highlighted key drug discovery and development predictions for 2023. Antheia was highlighted for its take on the synbio industry's renewed focus...
Industry News
In a recent Q&A with European Pharmaceutical Manufacturer Antheia CEO and co-founder Dr. Christina Smolke discussed how latency and variability within agricultural supply chains remains...
Industry News
Covid-19 has depleted stockpiles of essential medicines in the U.S., straining our supply chains and hobbling the treatment of critically ill patients....
Industry News
For millenniums, humans have harnessed yeast to brew beer. Now, in the latest advance in the fast-moving field of “synthetic biology,” a Stanford team is...
Industry News
This NSF Phase II award "A complete bioprocess for medicinal plant opioids" has built upon the early-stage R&D completed under the Phase I award (1621560)....
Industry News
Back in 2015, a 40-year-old synthetic biologist named Christina Smolke, along with a small team of researchers at Stanford, made a huge discovery. They proved...
Industry News
In the current age of life sciences, we have come to invent better and better drugs that are increasingly efficient in relieving pain and treating...
Industry News
In the Future of Everything radio show, Stanford bioengineers Russ Altman and Christina Smolke discuss advances in synthetic biology and the rise of opioids made...